In summary, the analysis across pan-cancer, germ cell origin, and individual histology revealed that the Zhang CD8 TCS signature demonstrated the best performance across the broadest scenarios in prognosticating OS and PFI for primary resected tumors. This evidence concerns the gene CD8A and cancer.